HK Stock MarketDetailed Quotes

02197 CLOVER BIO-B

Watchlist
  • 0.410
  • -0.005-1.20%
Market Closed Mar 28 16:08 CST
531.75MMarket Cap-3474P/E (TTM)

CLOVER BIO-B Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Turnover
--39.26M
--257K
----
----
----
----
----
----
Operating income
39.26M
257K
Cost of sales
---15.01M
---202K
----
----
----
----
----
----
Operating expenses
-15.01M
-202K
Gross profit
24.24M
55K
Selling expenses
---54.77M
---22.51M
----
----
----
----
----
----
Administrative expenses
51.54%-198.82M
51.42%-109.47M
-18.67%-410.24M
-80.56%-225.34M
-352.33%-345.71M
---124.8M
-348.66%-76.43M
---17.04M
Research and development expenses
55.65%-649.89M
54.91%-385.6M
19.77%-1.47B
-34.93%-855.27M
-700.24%-1.83B
---633.84M
-398.31%-228.22M
---45.8M
Revaluation surplus
----
----
----
----
-537.09%-3.81B
---555.88M
-6,564.67%-597.66M
--9.25M
-Changes in the fair value of other assets
----
----
----
----
-537.09%-3.81B
---555.88M
-6,564.67%-597.66M
--9.25M
Special items of operating profit
233.13%759.41M
2,313.70%1.18B
-1,905.81%-570.41M
-912.38%-53.3M
-273.30%-28.44M
--6.56M
-149.67%-7.62M
--15.34M
Operating profit
95.10%-119.82M
158.42%662.37M
59.29%-2.45B
13.31%-1.13B
-560.28%-6.01B
-1.31B
-2,278.83%-909.93M
-38.25M
Financing cost
-215.73%-18.72M
-439.69%-11.75M
27.82%-5.93M
67.93%-2.18M
-176.35%-8.22M
---6.79M
71.23%-2.97M
---10.33M
Earning before tax
94.35%-138.54M
157.27%650.62M
59.25%-2.45B
13.59%-1.14B
-559.03%-6.02B
-1.31B
-1,779.05%-912.9M
-48.58M
After-tax profit from continuing operations
94.35%-138.54M
157.27%650.62M
59.25%-2.45B
13.59%-1.14B
-559.03%-6.02B
-1.31B
-1,779.05%-912.9M
-48.58M
Earning after tax
94.35%-138.54M
157.27%650.62M
59.25%-2.45B
13.59%-1.14B
-559.03%-6.02B
-1.31B
-1,779.05%-912.9M
-48.58M
Profit attributable to shareholders
94.35%-138.54M
157.27%650.62M
59.25%-2.45B
13.59%-1.14B
-559.03%-6.02B
-1.31B
-1,779.05%-912.9M
-48.58M
Basic earnings per share
95.05%-0.11
149.52%0.52
82.95%-2.22
72.07%-1.05
-398.85%-13.02
-3.76
-169.07%-2.61
-0.97
Diluted earnings per share
95.05%-0.11
149.52%0.52
82.95%-2.22
72.07%-1.05
-398.85%-13.02
-3.76
-169.07%-2.61
-0.97
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Turnover --39.26M--257K------------------------
Operating income 39.26M257K
Cost of sales ---15.01M---202K------------------------
Operating expenses -15.01M-202K
Gross profit 24.24M55K
Selling expenses ---54.77M---22.51M------------------------
Administrative expenses 51.54%-198.82M51.42%-109.47M-18.67%-410.24M-80.56%-225.34M-352.33%-345.71M---124.8M-348.66%-76.43M---17.04M
Research and development expenses 55.65%-649.89M54.91%-385.6M19.77%-1.47B-34.93%-855.27M-700.24%-1.83B---633.84M-398.31%-228.22M---45.8M
Revaluation surplus -----------------537.09%-3.81B---555.88M-6,564.67%-597.66M--9.25M
-Changes in the fair value of other assets -----------------537.09%-3.81B---555.88M-6,564.67%-597.66M--9.25M
Special items of operating profit 233.13%759.41M2,313.70%1.18B-1,905.81%-570.41M-912.38%-53.3M-273.30%-28.44M--6.56M-149.67%-7.62M--15.34M
Operating profit 95.10%-119.82M158.42%662.37M59.29%-2.45B13.31%-1.13B-560.28%-6.01B-1.31B-2,278.83%-909.93M-38.25M
Financing cost -215.73%-18.72M-439.69%-11.75M27.82%-5.93M67.93%-2.18M-176.35%-8.22M---6.79M71.23%-2.97M---10.33M
Earning before tax 94.35%-138.54M157.27%650.62M59.25%-2.45B13.59%-1.14B-559.03%-6.02B-1.31B-1,779.05%-912.9M-48.58M
After-tax profit from continuing operations 94.35%-138.54M157.27%650.62M59.25%-2.45B13.59%-1.14B-559.03%-6.02B-1.31B-1,779.05%-912.9M-48.58M
Earning after tax 94.35%-138.54M157.27%650.62M59.25%-2.45B13.59%-1.14B-559.03%-6.02B-1.31B-1,779.05%-912.9M-48.58M
Profit attributable to shareholders 94.35%-138.54M157.27%650.62M59.25%-2.45B13.59%-1.14B-559.03%-6.02B-1.31B-1,779.05%-912.9M-48.58M
Basic earnings per share 95.05%-0.11149.52%0.5282.95%-2.2272.07%-1.05-398.85%-13.02-3.76-169.07%-2.61-0.97
Diluted earnings per share 95.05%-0.11149.52%0.5282.95%-2.2272.07%-1.05-398.85%-13.02-3.76-169.07%-2.61-0.97
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg